Global Biochips Market 2026-2030

Description

The global biochips market is forecasted to grow by USD 100836.5 mn during 2025-2030, accelerating at a CAGR of 28.3% during the forecast period. The report on the global biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by accelerating global shift precision oncology demanding multiplex biomarker analysis, rapid decentralization clinical testing toward point care microfluidics, pharmaceutical research and development pipeline expansion utilizing organ on chip platforms.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	27.5%
CAGR	28.3%
Incremental Value	$100836.5 mn

Technavio's global biochips market is segmented as below:

By End-User

Biotech and pharma companies
Hospitals and diagnostics centers
Academic and research institutes

By Technology

Microarrays
Microfluidics

By Product Type

DNA chip
Lab-on-a-chip
Protein chip
Others

Geography

North America
- US
- Canada
- Mexico
APAC
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
Middle East and Africa
- UAE
- South Africa
- Turkey
South America
- Brazil
- Argentina
- Chile
Rest of World (ROW)

This study identifies the integration semiconductor cmos sensors direct electronic biomarker signal detection as one of the prime reasons driving the global biochips market growth during the next few years. Also, implementation microfluidic continuous multiplex monitoring wearable patch biochips and shift toward synthetic aptamers biorecognition probes enhancing chip stability will lead to sizable demand in the market.

The report on the global biochips market covers the following areas:

Global biochips market sizing
Global biochips market forecast
Global biochips market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biochips market vendors that include Abbott Laboratories, Agilent Technologies Inc., Aline Inc., Atomica Corp., BD Biosciences, Bio Rad Laboratories Inc., Boao Bio Group Co. Ltd., F. Hoffmann La Roche Ltd., Illumina Inc., Macrogen Inc., Micronit BV, QIAGEN N.V., Randox Laboratories Ltd., RayBiotech Life Inc., Revvity Inc., Siemens Healthineers AG, Sony Biotechnology Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., Toray Industries Inc.. Also, the global biochips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR75193

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global Biochips Market 2020 - 2024
- Historic Market Size - Data Table on Global Biochips Market 2020 - 2024 ($ million)
5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.3 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on global biochips market
6.2 Impact of geopolitical conflicts on global biochips market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by End-user

8.1 Market segments
8.2 Comparison by End-user
8.3 Biotech and pharma companies - Market size and forecast 2025-2030
8.4 Hospitals and diagnostics centers - Market size and forecast 2025-2030
8.5 Academic and research institutes - Market size and forecast 2025-2030
8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)

9 Market Segmentation by Technology

9.1 Market segments
9.2 Comparison by Technology
9.3 Microarrays - Market size and forecast 2025-2030
9.4 Microfluidics - Market size and forecast 2025-2030
9.5 Market opportunity by Technology
- Market opportunity by Technology ($ million)

10 Market Segmentation by Product Type

10.1 Market segments
10.2 Comparison by Product Type
10.3 DNA chip - Market size and forecast 2025-2030
10.4 Lab-on-a-chip - Market size and forecast 2025-2030
10.5 Protein chip - Market size and forecast 2025-2030
10.6 Others - Market size and forecast 2025-2030
10.7 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
12.2 Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
12.4 APAC - Market size and forecast 2025-2030
- 12.4.1 China - Market size and forecast 2025-2030
- 12.4.2 Japan - Market size and forecast 2025-2030
- 12.4.3 India - Market size and forecast 2025-2030
- 12.4.4 South Korea - Market size and forecast 2025-2030
- 12.4.5 Australia - Market size and forecast 2025-2030
- 12.4.6 Indonesia - Market size and forecast 2025-2030
12.5 Europe - Market size and forecast 2025-2030
- 12.5.1 Germany - Market size and forecast 2025-2030
- 12.5.2 UK - Market size and forecast 2025-2030
- 12.5.3 France - Market size and forecast 2025-2030
- 12.5.4 Italy - Market size and forecast 2025-2030
- 12.5.5 Spain - Market size and forecast 2025-2030
- 12.5.6 The Netherlands - Market size and forecast 2025-2030
12.6 Middle East and Africa - Market size and forecast 2025-2030
- 12.6.1 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.2 UAE - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 Israel - Market size and forecast 2025-2030
- 12.6.5 Turkey - Market size and forecast 2025-2030
12.7 South America - Market size and forecast 2025-2030
- 12.7.1 Brazil - Market size and forecast 2025-2030
- 12.7.2 Argentina - Market size and forecast 2025-2030
- 12.7.3 Chile - Market size and forecast 2025-2030
12.8 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Accelerating global shift precision oncology demanding multiplex biomarker analysis
- Rapid decentralization clinical testing toward point care microfluidics
- Pharmaceutical research and development pipeline expansion utilizing organ on chip platforms
13.2 Market challenges
- High initial microfabrication cleanroom production costs restricting commercial accessibility
- Biological surface functionalization inconsistencies causing batch reliability impairment
- Complex interoperability gaps legacy diagnostic equipment impeding integration
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Integration semiconductor cmos sensors direct electronic biomarker signal detection
- Implementation microfluidic continuous multiplex monitoring wearable patch biochips
- Shift toward synthetic aptamers biorecognition probes enhancing chip stability

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
15.6 Aline Inc.
- Aline Inc. - Overview
- Aline Inc. - Product / Service
- Aline Inc. - Key offerings
- SWOT
15.7 BD Biosciences
- BD Biosciences - Overview
- BD Biosciences - Product / Service
- BD Biosciences - Key offerings
- SWOT
15.8 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
15.9 Boao Bio Group Co. Ltd.
- Boao Bio Group Co. Ltd. - Overview
- Boao Bio Group Co. Ltd. - Product / Service
- Boao Bio Group Co. Ltd. - Key offerings
- SWOT
15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.11 Macrogen Inc.
- Macrogen Inc. - Overview
- Macrogen Inc. - Product / Service
- Macrogen Inc. - Key offerings
- SWOT
15.12 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
15.13 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
15.14 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
15.15 Sony Biotechnology Inc.
- Sony Biotechnology Inc. - Overview
- Sony Biotechnology Inc. - Product / Service
- Sony Biotechnology Inc. - Key offerings
- SWOT
15.16 Takara Holdings Inc.
- Takara Holdings Inc. - Overview
- Takara Holdings Inc. - Business segments
- Takara Holdings Inc. - Key offerings
- Takara Holdings Inc. - Segment focus
- SWOT
15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
15.18 Toray Industries Inc.
- Toray Industries Inc. - Overview
- Toray Industries Inc. - Business segments
- Toray Industries Inc. - Key news
- Toray Industries Inc. - Key offerings
- Toray Industries Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations